Merck and Huma Therapeutics launch innovative app to support bladder cancer patients
Posted:
London headquartered Huma Therapeutics, together with Germany's Merck KGaA, has announced the launch of their innovative bladder cancer treatment companion app in the United Kingdom.
The first participants have been recruited in Oxford for a new multinational clinical trial that will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD).
Read more here.
Leeds Teaching Hospitals NHS Trust (LTHT) is piloting an AI solution, designed by Lucida Medical, to assess whether it can improve prostate cancer diagnosis.
Read the full article here.